Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Heart Outcomes Prevention Evaluation study

Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and mi-crovascular outcomes in people with diabetes melli-tus results of the HOPE study and MICRO-HOPE substudy. Lancet 2000 355 253-9. [Pg.597]

Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 342 154-160. [Pg.236]

HOPE Heart Outcomes Prevention Evaluation study... [Pg.458]

Anon. Effects of ramipril on cardiovascular and microvas-cular outcomes in people with diabetes meUitus Results of the hope study and micro-hope substudy. Heart outcomes prevention evaluation study investigators. Lancet. 2000 355 253-259... [Pg.24]

Dagenais, GE... Yusuf, S., Bourassa, M.G., Yi, QJ-.., Bosch, J., Lonn, E.M., Kouz, S., Grover, J., and Investigators, H.O.P.E. (2001) Effects of Ramipril on Coronary Events in High-Risk Persons—Results of the Heart Outcomes Prevention Evaluation Study, Circulation 104,522 526. [Pg.203]

Heart Outcomes Prevention Evaluation Study (HOPE) Investigators (2000) Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients, N. Engl. J. Med. 342, 154-160. [Pg.210]

Epidemiological studies have suggested that an increase of 3 mmHg in blood pressure is associated with a 10-20% increase in congestive heart failure (ALLHAT Collaborative Research Group 2000). Conversely, a 3 mmHg reduction in blood pressure in hypertensive individuals decreases risk of myocardial infarction by 22 % and of stroke by 33 % (Heart Outcomes Prevention Evaluation Study Investigators... [Pg.207]

Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes meUitus results of the HOPE study and MICRO-HOPE substudy. Lancet 355 253-259 Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 2335-2342 Kozloff M, Yood MU, Berlin J et al (2009) Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer the BRiTE observational cohort study. Oncologist 14 862-870... [Pg.215]

ACE, angiotensin converting enzyme ATBC, Alpha Tocopherol Beta Carotene Prevention Study CHAOS, Cambridge Heart Antioxidant Study GiSSi, GiSSI Prevenzione Triai HOPE, Heart Outcomes Prevention Evaluation Study HPS, Heart Protection Study CHD, Coronary Heart Disease CVD, cardiovascuiar disease Ml, myocardial infarction PUPA, polyunsatutated fatty acids. [Pg.34]

See other pages where Heart Outcomes Prevention Evaluation study is mentioned: [Pg.1297]    [Pg.20]    [Pg.31]    [Pg.1297]    [Pg.696]    [Pg.234]    [Pg.122]    [Pg.291]    [Pg.216]    [Pg.258]    [Pg.318]    [Pg.39]    [Pg.195]    [Pg.43]    [Pg.235]    [Pg.32]   
See also in sourсe #XX -- [ Pg.695 ]

See also in sourсe #XX -- [ Pg.30 , Pg.32 , Pg.34 , Pg.37 ]



SEARCH



Heart Outcomes Prevention

Heart Outcomes Prevention Evaluation

Outcome evaluation

Outcome studies

Prevention Studies

© 2024 chempedia.info